BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1489002)

  • 1. Deposition and removal of cutaneous beta 2-microglobulin.
    Spiegel DM; Costante N; Janiga AM; Haas M; Soltani K
    Am J Nephrol; 1992; 12(5):330-5. PubMed ID: 1489002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of beta 2-microglobulin skin deposits in dialyzed patients and healthy controls.
    Assounga AG; Bascoul S; Canaud B; Bouya PA; Vendrell JP; Sciolla JP; Mourad G; Baldet P; Serre A; Mion C
    Am J Kidney Dis; 1990 Jun; 15(6):556-61. PubMed ID: 2195873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 2-microglobulin levels in patients with renal insufficiency.
    Acchiardo S; Kraus AP; Jennings BR
    Am J Kidney Dis; 1989 Jan; 13(1):70-4. PubMed ID: 2643313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures.
    Mayer G; Thum J; Woloszczuk W; Graf H
    Am J Nephrol; 1988; 8(4):280-4. PubMed ID: 3055992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 2-microglobulin elimination in end-stage renal disease patients on renal replacement therapy.
    Stefanović V; Kostić S; Djordjević V; Mitić M; Bogicević M
    Perit Dial Int; 1993; 13 Suppl 2():S520-2. PubMed ID: 8399654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 2-microglobulin deposition in bone in chronic renal failure.
    Onishi S; Andress DL; Maloney NA; Coburn JW; Sherrard DJ
    Kidney Int; 1991 May; 39(5):990-5. PubMed ID: 2067215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis.
    Garbar C; Jadoul M; Noël H; van Ypersele de Strihou C
    Kidney Int; 1999 May; 55(5):1983-90. PubMed ID: 10231463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generalized beta 2-microglobulin deposition. A preamyloidosis disorder?
    Terreros DA; Knight JA; Peric-Golia L; Cheung AK
    Arch Pathol Lab Med; 1989 Jan; 113(1):31-5. PubMed ID: 2491942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta 2-microglobulin amyloidosis in hemodialysis patients. An autopsy study of intervertebral disks and posterior longitudinal ligaments.
    Honda K; Hara M; Ogura Y; Nihei H; Mimura N
    Acta Pathol Jpn; 1990 Nov; 40(11):820-6. PubMed ID: 2127652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum beta 2-microglobulin concentration in dialysis patients: importance of intrinsic renal function.
    McCarthy JT; Williams AW; Johnson WJ
    J Lab Clin Med; 1994 Apr; 123(4):495-505. PubMed ID: 8144998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Beta 2-microglobulin--its role in renal failure and hemodialysis therapy].
    Czyz W; Szepietowski T
    Postepy Hig Med Dosw; 1992; 46(2):209-38. PubMed ID: 1470582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating form of beta-2-microglobulin in dialysis patients.
    Gagnon RF; Somerville P; Thomson DM
    Am J Nephrol; 1988; 8(5):379-83. PubMed ID: 3071144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis.
    Gorevic PD; Munoz PC; Casey TT; DiRaimondo CR; Stone WJ; Prelli FC; Rodrigues MM; Poulik MD; Frangione B
    Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7908-12. PubMed ID: 3532124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dialysis arthropathy: outcome after renal transplantation.
    Bardin T; Lebail-Darné JL; Zingraff J; Laredo JD; Voisin MC; Kreis H; Kuntz D
    Am J Med; 1995 Sep; 99(3):243-8. PubMed ID: 7653483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumoral amyloidosis of bone of beta 2-microglobulin origin in association with long-term hemodialysis: a new type of amyloid disease.
    Casey TT; Stone WJ; DiRaimondo CR; Brantley BD; DiRaimondo CV; Gorevic PD; Page DL
    Hum Pathol; 1986 Jul; 17(7):731-8. PubMed ID: 3087858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum amyloid P component: a predictor of clinical beta 2-microglobulin amyloidosis.
    Spiegel DM; Sprague SM
    Am J Kidney Dis; 1992 May; 19(5):427-32. PubMed ID: 1585929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of amyloid-like substance from beta-2-microglobulin in vitro. Role of serum amyloid P component: a preliminary study.
    Ono K; Uchino F
    Nephron; 1994; 66(4):404-7. PubMed ID: 8015642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta 2 microglobulin in the blood pf patients with chronic renal failure treated by hemodialysis and kidney transplantation].
    Wiecek A; Kokot F; Kochańska-Dziurowicz A; Grzeszczak W; Zukowska-Szczechowska E
    Pol Arch Med Wewn; 1989 Feb; 81(2):100-6. PubMed ID: 2694120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column.
    Ohashi K; Hara M; Kawai R; Ogura Y; Honda K; Nihei H; Mimura N
    Kidney Int; 1992 Jun; 41(6):1646-52. PubMed ID: 1501421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rheumatologic and radiologic symptoms of dialysis-associated beta 2-microglobulin amyloidosis: long-term retrospective study of 175 chronic hemodialysis patients].
    Hermann E; Mayet WJ; Wandel E; Scherer G; Schadmand S; Klose KJ; Poralla T; Meyer zum Büschenfelde KH; Köhler H
    Z Rheumatol; 1991; 50(3):160-7. PubMed ID: 1927061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.